Why are tumour blood vessels abnormal and why is it important to know? - Wikidata - awgldk - TriplyDB

Why are tumour blood vessels abnormal and why is it important to know?

Why are tumour blood vessels abnormal and why is it important to know?

http://www.wikidata.org/entity/Q24652018

about

Colorectal cancer development and advances in screening VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside Molecular control of capillary morphogenesis and maturation by recognition and remodeling of the extracellular matrix: functional roles of endothelial cells and pericytes in health and disease Tumor endothelial cells Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.Ultrasensitive detection of 3D cerebral microvascular network dynamics in vivo Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases Computational Model for Tumor Oxygenation Applied to Clinical Data on Breast Tumor Hemoglobin Concentrations Suggests Vascular Dilatation and Compression Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad The Role of CC-Chemokines in the Regulation of Angiogenesis The ever-expanding role of HIF in tumour and stromal biology The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation Systems biology of pro-angiogenic therapies targeting the VEGF system Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Normalization of the vasculature for treatment of cancer and other diseases.Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks.Macromolecule extravasation-xenograft size matters: a systematic study using probe-based confocal laser endomicroscopy (pCLE)Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.Tumor-derived VEGF modulates hematopoiesis Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors.Endogenous AJAP1 associates with the cytoskeleton and attenuates angiogenesis in endothelial cells Cdc42-mediated inhibition of GSK-3β improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis.A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment Basement membrane-rich organoids with functional human blood vessels are permissive niches for human breast cancer metastasis.Dehydro-alpha-lapachone, a plant product with antivascular activity.Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.A new mechanism for pillar formation during tumor-induced intussusceptive angiogenesis: inverse sprouting Tumor microenvironment and progression.Heterogeneity of the tumor vasculature.AECHL-1, a novel triterpenoid, targets tumor neo-vasculature and impairs the endothelial cell cytoskeleton.The Role of Genetically Modified Mesenchymal Stem Cells in Urinary Bladder Regeneration.Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment.Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.Ophthalmic artery occlusion following neuro-embolization of the external carotid artery, a case report.NAADP-Dependent Ca(2+) Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis Molecular targeting of liposomal nanoparticles to tumor microenvironment.

P2860

Q26739885-3FF981E9-7EC8-4C09-B042-47CF34E59766 Q26770678-0DEAFF91-2498-4269-A8FF-025BC77E292C Q26797500-A8469026-9BB0-4E2E-9E12-E2C9F1A26565 Q26995733-4A482BB8-369B-4769-86DC-D88AF0871C04 Q27000351-792FEBCE-E1A7-4731-A0CB-4018711F77B0 Q27300805-BB2C5E09-1D0B-42D9-9F5F-BF11C15D2C5B Q27307630-0640736D-EB19-4837-8D0B-DB96A5EDC06D Q27312628-1830C99D-4D58-4F15-853A-DC3A35E54921 Q27327081-9CC9BE7D-98FB-4FBD-91B1-9D1CB8662F14 Q27330438-F4BAA199-EA5E-4805-8AE9-C484A4A85539 Q28077024-F44DE4D7-DD88-4514-BA5A-A61CF606FCC9 Q28079015-300AB6C4-BA04-474E-86AE-F3FD5AE5B277 Q28291406-6F7ED0DE-EE5A-44B7-87CB-7F54A29783DD Q30430112-A28972AB-E68E-41A1-BCEA-2B46A3D013E2 Q30469815-BE112ECC-2180-4310-80A7-9A066780FFC6 Q30471456-E32DB3BB-5F3E-4F81-8649-C248A1CC6E4A Q30496044-DDB8AB28-950F-4BC0-B588-28E252D8DE26 Q30557217-A73271C0-952F-473A-B5B7-3BC0E5E6251F Q30651792-8D18F457-0782-45D2-863D-1160581D41D9 Q33592159-FF3A5EC7-31AD-4CF3-95D0-F16BB95F3A77 Q33709517-7E50FCE3-CC44-4956-975B-E29EE7596F5C Q33712485-2BA5CFA3-611A-413B-BE9C-5E0BBCAE92CF Q33738607-579616AA-9159-4F8D-A07C-1628CD833539 Q33830536-F56CBE67-DE3D-41B1-814E-3EA5AE7972D9 Q34491380-F8BFA222-FCD4-46C7-9FCB-FB9EE3EF74E4 Q34765364-6971376C-9AFD-491B-833E-2AB0F2021AA0 Q34951833-3148A28B-D63E-4D4A-BCE6-6B7127620C79 Q35105219-6244D188-0765-427B-8F0E-293869C7AA26 Q35165488-B77FF0ED-F427-4171-9267-DC9890BB1208 Q35168262-5D3A980A-C123-4C4D-ACF1-C80AF176FD64 Q35752272-3AFF0BE0-4948-4261-92E4-77CBC9B1D884 Q35752502-935633F9-99E3-491D-A694-779F9B638840 Q35757079-67F10BBF-A2CA-42BB-948D-044114DBB1FD Q35785287-CC169E30-5FA8-4243-8B11-4957B9D03DCE Q35823514-FD850A3B-8026-410A-9A2B-A38B45EE5B5C Q36016318-EA291EFA-5729-4C4B-B5F0-12077EE810C0 Q36246720-A0B519C2-57B0-4C10-9C44-6602A98D3DAA Q36406708-6B182468-CDB9-4F7F-9F45-71BBC1625CD3 Q36432462-76C366CA-4320-4150-8819-933E2F842A1A Q36500108-5CA6F329-2518-4F71-9DC8-6E0333CF42B9

P2860

Why are tumour blood vessels abnormal and why is it important to know?

http://www.wikidata.org/entity/Q24652018

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Why are tumour blood vessels abnormal and why is it important to know?

@ast

Why are tumour blood vessels abnormal and why is it important to know?

@en

Why are tumour blood vessels abnormal and why is it important to know?

@nl

type

label

Why are tumour blood vessels abnormal and why is it important to know?

@ast

Why are tumour blood vessels abnormal and why is it important to know?

@en

Why are tumour blood vessels abnormal and why is it important to know?

@nl

prefLabel

Why are tumour blood vessels abnormal and why is it important to know?

@ast

Why are tumour blood vessels abnormal and why is it important to know?

@en

Why are tumour blood vessels abnormal and why is it important to know?

@nl

P1433

Q24652018-B6CB5537-8A73-4354-876D-E6C3DE4B96DF

P1476

Q24652018-0956F61D-960C-43A6-92C4-2B4EB4C221B1

P2093

Q24652018-2D65ED9A-5797-491D-936D-A1534A97F596

Q24652018-76CB0617-0521-4912-9766-95EEFE673FE2

Q24652018-8758ABA1-621F-4BA0-A23A-39D427C6261A

Q24652018-C437413A-49C2-4403-85CC-A271C8069A18

P2860

Q24652018-1235D30F-BE30-420E-A97B-5983243F2847

Q24652018-1DC4C191-90D3-4487-843B-A2744694A679

Q24652018-25C70DC9-101C-4021-B030-33F7590BE297

Q24652018-267BA893-4700-4F8A-BF12-00F1F3E2CD51

Q24652018-28389C33-4032-4498-99D3-BBD7B7B6953B

Q24652018-2875DE46-AF95-4461-9AD4-D42CF4F6E95E

Q24652018-28D4D438-655D-406D-8FD0-A08E0C679771

Q24652018-2B716C78-9A34-457C-9930-37870E0A4986

Q24652018-38B1EBF2-6ECD-4570-8DCC-A46BDC51B640

Q24652018-4A26EDF9-A74C-426F-8F1B-5BD9D8BA7AEA

P2888

Q24652018-E906B5FF-C143-4702-864A-0198CFC77ADF

P304

Q24652018-6CD248FD-3BE9-487C-819F-8F4A63D07E81

P31

Q24652018-43E759A5-4B29-44CE-9EED-D3F7DFB6CB5F

Q24652018-E5B44AAB-3835-46FB-8B47-B3BC10156531

P3181

Q24652018-8D8C60FB-2F60-46EE-91C8-5E9997D7B18E

P356

Q24652018-B7D7B860-AE1F-441E-A770-02CF79043003

P407

Q24652018-F86EC921-2623-4539-B85D-EF971E68A1B8

P433

Q24652018-312E0B99-C5BF-47E5-B345-FFBC7224C684

P478

Q24652018-5BB9191D-4444-452E-A731-D70EBEFCEAE9

P577

Q24652018-046523DF-74CD-4399-B836-41841C0E2FC3

P5875

Q24652018-0474A58A-05FE-4E23-B020-0D387D0907D6

P6179

Q24652018-D599066D-DABC-41A5-A345-39CB670F9C5A

P698

Q24652018-619386FF-FE4E-4B1C-B1DD-34D35B33FDF4

P921

Q24652018-11AD3AB3-21E2-4CE7-A752-2787BF03CCA3

P932

Q24652018-74E905EF-846D-45F6-97CC-5CDC207B2BD2

P3181

P356

P1433

British Journal of Cancer

P1476

Why are tumour blood vessels abnormal and why is it important to know?

@en

P2093

A M Dvorak

http://www.w3.org/2001/XMLSchema#string

H F Dvorak

http://www.w3.org/2001/XMLSchema#string

J A Nagy

http://www.w3.org/2001/XMLSchema#string

S-H Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

Tumor angiogenesis: therapeutic implications

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis

Vasculogenic mimicry and tumor angiogenesis.

Unorthodox angiogenesis in skeletal muscle.

First steps of tumor-related angiogenesis.

VEGF-A and the induction of pathological angiogenesis.

Vascular permeability, vascular hyperpermeability and angiogenesis

P2888

P304

865-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

524676

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.BJC.6604929

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24038176

http://www.w3.org/2001/XMLSchema#string

P6179

1016734753

http://www.w3.org/2001/XMLSchema#string

P698

19240721

http://www.w3.org/2001/XMLSchema#string

P921

P932

2661770

http://www.w3.org/2001/XMLSchema#string